Meliora Therapeutics
The company specializes in creating precision oncology drugs using machine learning and modern molecular fingerprinting to improve drug development and reduce the failure rate of cancer therapies.
Services
Meliora Therapeutics specializes in the development of precision oncology drugs leveraging cutting-edge machine learning technologies. The company provides novel mechanistic insights on existing molecules and identifies promising starting scaffolds for new drug discovery programs. Meliora Therapeutics offers a platform that screens compounds to identify valuable starting scaffolds for high-value cancer targets. By partnering with other organizations, Meliora also contributes to the exploration of functional cancer biology and the development of new drugs.
Products
Meliora Therapeutics has developed a proprietary platform named AnchorOmics, used to map anti-cancer drug mechanisms of action. This target-agnostic mechanism-of-action atlas helps in identifying potent compounds for cancer therapy and functions as a prediction engine to unveil the true mechanisms of action of various molecules. Additionally, the platform assists in nominating drug scaffolds for future development, thereby reducing the cost and time required for the drug development process.
Technology
The technological backbone of Meliora Therapeutics merges modern molecular fingerprinting with machine learning and advanced biology. The company utilizes a machine learning-powered atlas to create a comprehensive picture of drug interactions with cancer biology, employing bio-functional readouts and computational techniques. Functional genomics powered by machine learning is applied at scale to facilitate drug discovery, improving the overall accuracy in identifying the true mechanisms-of-action of therapeutic agents.
Funding
Meliora Therapeutics has successfully raised $11 million in seed financing aimed at advancing its cancer treatment initiatives. This funding aids in the continual development of their machine learning-powered drug discovery platforms and supports their ongoing research and partnership projects in the field of precision oncology.
Publications
To contribute to the broader scientific community and advance the field of cancer research, Meliora Therapeutics publishes peer-reviewed articles and preprints. These publications share insights into their innovative approaches to drug discovery and the application of machine learning and functional genomics to develop more effective cancer therapies.